{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:32:46Z","timestamp":1786980766039,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T00:00:00Z","timestamp":1323388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s10549-011-1903-6","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T00:40:56Z","timestamp":1323304856000},"page":"31-40","source":"Crossref","is-referenced-by-count":25,"title":["Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model"],"prefix":"10.1007","volume":"134","author":[{"given":"Yoanne","family":"Mousseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Mollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Faucher-Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Nizou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Cook-Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Baaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Plainard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Funalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck G.","family":"Sturtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,9]]},"reference":[{"issue":"8","key":"1903_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ajh.21745","volume":"85","author":"A Raza","year":"2010","unstructured":"Raza A, Franklin MJ, Dudek AZ (2010) Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 85(8):593\u2013598","journal-title":"Am J Hematol"},{"issue":"10","key":"1903_CR2","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI24612","volume":"116","author":"MR Mancuso","year":"2006","unstructured":"Mancuso MR, Davis R, Norberg SM, O\u2019Brien S, Sennino B, Nakahara T, Yao VJ, Inai T, Brooks P, Freimark B et al (2006) Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 116(10):2610\u20132621","journal-title":"J Clin Invest"},{"issue":"9","key":"1903_CR3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","volume":"111","author":"G Bergers","year":"2003","unstructured":"Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111(9):1287\u20131295","journal-title":"J Clin Invest"},{"issue":"3","key":"1903_CR4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1634\/theoncologist.11-3-274","volume":"11","author":"P Maione","year":"2006","unstructured":"Maione P, Gridelli C, Troiani T, Ciardiello F (2006) Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC. Oncologist 11(3):274\u2013284","journal-title":"Oncologist"},{"issue":"1","key":"1903_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jvs.2004.08.058","volume":"41","author":"WJ Tanski","year":"2005","unstructured":"Tanski WJ, Nicholl SM, Kim D, Fegley AJ, Roztocil E, Davies MG (2005) Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin. J Vasc Surg 41(1):91\u201398","journal-title":"J Vasc Surg"},{"issue":"6","key":"1903_CR6","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2353\/ajpath.2006.060196","volume":"169","author":"VS Rajkumar","year":"2006","unstructured":"Rajkumar VS, Shiwen X, Bostrom M, Leoni P, Muddle J, Ivarsson M, Gerdin B, Denton CP, Bou-Gharios G, Black CM et al (2006) Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J pathol 169(6):2254\u20132265","journal-title":"Am J pathol"},{"issue":"11","key":"1903_CR7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mc.20248","volume":"45","author":"S Banerjee","year":"2006","unstructured":"Banerjee S, Sengupta K, Dhar K, Mehta S, D\u2019Amore PA, Dhar G, Banerjee SK et al (2006) Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1. Mol Carcinog 45(11):871\u2013880","journal-title":"Mol Carcinog"},{"issue":"10","key":"1903_CR8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4331\/wjbc.v1.i10.298","volume":"1","author":"Y Takuwa","year":"2010","unstructured":"Takuwa Y, Du W, Qi X, Okamoto Y, Takuwa N, Yoshioka K (2010) Roles of sphingosine-1-phosphate signaling in angiogenesis. World J Biol Chem 1(10):298\u2013306","journal-title":"World J Biol Chem"},{"issue":"7","key":"1903_CR9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc2875","volume":"10","author":"NJ Pyne","year":"2010","unstructured":"Pyne NJ, Pyne S (2010) Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10(7):489\u2013503","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1903_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1043-6618(03)00046-X","volume":"47","author":"T Hla","year":"2003","unstructured":"Hla T (2003) Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res 47(5):401\u2013407","journal-title":"Pharmacol Res"},{"issue":"5","key":"1903_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semcdb.2004.05.002","volume":"15","author":"T Hla","year":"2004","unstructured":"Hla T (2004) Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 15(5):513\u2013520","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"1903_CR12","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/MCB.25.10.4237-4249.2005","volume":"25","author":"SK Goparaju","year":"2005","unstructured":"Goparaju SK, Jolly PS, Watterson KR, Bektas M, Alvarez S, Sarkar S, Mel L, Ishii I, Chun J, Milstien S et al (2005) The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol Cell Biol 25(10):4237\u20134249","journal-title":"Mol Cell Biol"},{"issue":"10","key":"1903_CR13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/CIRCRESAHA.107.159228","volume":"101","author":"T Shimizu","year":"2007","unstructured":"Shimizu T, Nakazawa T, Cho A, Dastvan F, Shilling D, Daum G, Reidy MA (2007) Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries. Circ Res 101(10):995\u20131000","journal-title":"Circ Res"},{"issue":"4","key":"1903_CR14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/cvr\/cvn118","volume":"79","author":"S Takashima","year":"2008","unstructured":"Takashima S, Sugimoto N, Takuwa N, Okamoto Y, Yoshioka K, Takamura M, Takata S, Kaneko S, Takuwa Y (2008) G12\/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. Cardiovasc Res 79(4):689\u2013697","journal-title":"Cardiovasc Res"},{"issue":"8","key":"1903_CR15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.tips.2011.04.002","volume":"32","author":"NJ Pyne","year":"2011","unstructured":"Pyne NJ, Pyne S (2011) Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow? Trends Pharmacol Sci 32(8):443\u2013450","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"1903_CR16","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.bcp.2007.12.018","volume":"75","author":"A Huwiler","year":"2008","unstructured":"Huwiler A, Pfeilschifter J (2008) New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets. Biochem Pharmacol 75(10):1893\u20131900","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"1903_CR17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","volume":"9","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9(11):883\u2013897","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1903_CR18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1096\/fj.03-0910fje","volume":"18","author":"MH Graler","year":"2004","unstructured":"Graler MH, Goetzl EJ (2004) The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J 18(3):551\u2013553","journal-title":"FASEB J"},{"issue":"10","key":"1903_CR19","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cellsig.2010.05.022","volume":"22","author":"F Tonelli","year":"2010","unstructured":"Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, Bittman R, Pyne S, Pyne NJ (2010) FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal 22(10):1536\u20131542","journal-title":"Cell Signal"},{"issue":"6","key":"1903_CR20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1248\/bpb.31.1177","volume":"31","author":"Y Nagaoka","year":"2008","unstructured":"Nagaoka Y, Otsuki K, Fujita T, Uesato S (2008) Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells. Biol Pharm Bull 31(6):1177\u20131181","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"1903_CR21","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1158\/0008-5472.CAN-07-2621","volume":"68","author":"JH Hung","year":"2008","unstructured":"Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, Kulp SK, Muthusamy N, Byrd JC, Cheng AL, Chen CS (2008) FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Res 68(4):1204\u20131212","journal-title":"Cancer Res"},{"issue":"1","key":"1903_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/0008-5472.CAN-05-2001","volume":"66","author":"K LaMontagne","year":"2006","unstructured":"LaMontagne K, Littlewood-Evans A, Schnell C, O\u2019Reilly T, Wyder L, Sanchez T, Probst B, Butler J, Wood A, Liau G et al (2006) Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res 66(1):221\u2013231","journal-title":"Cancer Res"},{"issue":"4","key":"1903_CR23","first-page":"460","volume":"1","author":"N Takuwa","year":"2011","unstructured":"Takuwa N, Du W, Kaneko E, Okamoto Y, Yoshioka K, Takuwa Y (2011) Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1\u2014Jekyll Hidden behind Hyde. Am J Cancer Res 1(4):460\u2013481","journal-title":"Am J Cancer Res"},{"issue":"2","key":"1903_CR24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2007.02.156","volume":"356","author":"R Roskoski Jr","year":"2007","unstructured":"Roskoski R Jr (2007) Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun 356(2):323\u2013328","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1903_CR25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrclinonc.2009.52","volume":"6","author":"VL Heath","year":"2009","unstructured":"Heath VL, Bicknell R (2009) Anticancer strategies involving the vasculature. Nat Rev Clin Oncol 6(7):395\u2013404","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"1903_CR26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/01.HYP.26.5.771","volume":"26","author":"A Sachinidis","year":"1995","unstructured":"Sachinidis A, Flesch M, Ko Y, Schror K, Bohm M, Dusing R, Vetter H (1995) Thromboxane A2 and vascular smooth muscle cell proliferation. Hypertension 26(5):771\u2013780","journal-title":"Hypertension"},{"issue":"10","key":"1903_CR27","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1074\/jbc.275.10.6758","volume":"275","author":"HY Kwan","year":"2000","unstructured":"Kwan HY, Huang Y, Yao X (2000) Store-operated calcium entry in vascular endothelial cells is inhibited by cGMP via a protein kinase G-dependent mechanism. J Biol Chem 275(10):6758\u20136763","journal-title":"J Biol Chem"},{"issue":"4","key":"1903_CR28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2144\/000112557","volume":"43","author":"Y Mousseau","year":"2007","unstructured":"Mousseau Y, Leclers D, Faucher-Durand K, Cook-Moreau J, Lia-Baldini AS, Rigaud M, Sturtz FG et al (2007) Improved agarose gel assay for quantification of growth factor-induced cell motility. Biotechniques 43(4):509\u2013516","journal-title":"Biotechniques"},{"issue":"2","key":"1903_CR29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1525-0016(03)00165-5","volume":"8","author":"MJ Li","year":"2003","unstructured":"Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, Kim J, Li S, Castanotto D, Zaia J, Rossi JJ (2003) Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther 8(2):196\u2013206","journal-title":"Mol Ther"},{"key":"1903_CR30","doi-asserted-by":"crossref","unstructured":"Kaipparettu BA, Kuiatse I, Tak-Yee Chan B, Benny Kaipparettu M, Lee AV, Oesterreich S (2008) Novel egg white-based 3-D cell culture system. Biotechniques 45(2):165\u2013168, 170\u2013171","DOI":"10.2144\/000112883"},{"issue":"9","key":"1903_CR31","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1172\/JCI31123","volume":"117","author":"A Skoura","year":"2007","unstructured":"Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T (2007) Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Investig 117(9):2506\u20132516","journal-title":"J Clin Investig"},{"issue":"8","key":"1903_CR32","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.yexcr.2007.02.009","volume":"313","author":"N Young","year":"2007","unstructured":"Young N, Van Brocklyn JR (2007) Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. Exp Cell Res 313(8):1615\u20131627","journal-title":"Exp Cell Res"},{"issue":"3","key":"1903_CR33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1096\/fj.02-0340fje","volume":"17","author":"H Cho","year":"2003","unstructured":"Cho H, Kozasa T, Bondjers C, Betsholtz C, Kehrl JH (2003) Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J 17(3):440\u2013442","journal-title":"FASEB J"},{"issue":"2","key":"1903_CR34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1096\/fj.03-0302fje","volume":"18","author":"LM Baudhuin","year":"2004","unstructured":"Baudhuin LM, Jiang Y, Zaslavsky A, Ishii I, Chun J, Xu Y (2004) S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). FASEB J 18(2):341\u2013343","journal-title":"FASEB J"},{"key":"1903_CR35","doi-asserted-by":"crossref","unstructured":"Mollard S, Mousseau Y, Baaj Y, Richard L, Cook-Moreau J, Monteil J, Funalot B, Sturtz FG (2011) How can grafted breast cancer models be optimized? Cancer Biol Ther 12(10):855\u2013864","DOI":"10.4161\/cbt.12.10.18139"},{"issue":"5","key":"1903_CR36","first-page":"1410","volume":"62","author":"H Azuma","year":"2002","unstructured":"Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y, Morimoto J, Fukui R, Hoshiga M, Ishihara T et al (2002) Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res 62(5):1410\u20131419","journal-title":"Cancer Res"},{"issue":"28","key":"1903_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000476","volume":"9","author":"M Murph","year":"2007","unstructured":"Murph M, Mills GB (2007) Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression. Expert Mol Med 9(28):1\u201318","journal-title":"Expert Mol Med"},{"issue":"16","key":"1903_CR38","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1016\/j.bmc.2008.07.003","volume":"16","author":"S Nakayama","year":"2008","unstructured":"Nakayama S, Uto Y, Tanimoto K, Okuno Y, Sasaki Y, Nagasawa H, Nakata E, Arai K, Momose K, Fujita T et al (2008) TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activity. Bioorganic medicinal chem 16(16):7705\u20137714","journal-title":"Bioorganic medicinal chem"},{"issue":"8","key":"1903_CR39","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/ATVBAHA.107.159392","volume":"28","author":"BR Wamhoff","year":"2008","unstructured":"Wamhoff BR, Lynch KR, Macdonald TL, Owens GK (2008) Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 28(8):1454\u20131461","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1903_CR40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1593\/neo.91880","volume":"12","author":"NE Campbell","year":"2010","unstructured":"Campbell NE, Greenaway J, Henkin J, Moorehead RA, Petrik J (2010) The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer. Neoplasia 12(3):275\u2013283","journal-title":"Neoplasia"},{"issue":"8","key":"1903_CR41","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00432-010-0770-6","volume":"136","author":"G Huang","year":"2010","unstructured":"Huang G, Chen L (2010) Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma. J Cancer Res Clin Oncol 136(8):1201\u20131211","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"1903_CR42","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ijrobp.2009.12.010","volume":"76","author":"MC McGee","year":"2010","unstructured":"McGee MC, Hamner JB, Williams RF, Rosati SF, Sims TL, Ng CY, Gaber MW, Calabrese C, Wu J, Nathwani AC et al (2010) Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. Int J Radiat Oncol Biol Phys 76(5):1537\u20131545","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1903-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1903-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1903-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T11:05:03Z","timestamp":1561028703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1903-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1903-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,9]]}}}